Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00878904
First received: April 8, 2009
Last updated: January 15, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2015
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)